^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GI-101

    i
    Company:
    GI Innovation, Simcere
    Drug class:
    PD-L1 inhibitor, CTLA4 inhibitor, CD122 agonist
    Related drugs: